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Biochemical and genetic analysis of Ecm14,
a conserved fungal pseudopeptidase
R. Christian McDonald, Matthew J. Schottˆ, Temitope A. Idowu and Peter J. Lyons*
Abstract
Background: Like most major enzyme families, the M14 family of metallocarboxypeptidases (MCPs) contains a
number of pseudoenzymes predicted to lack enzyme activity and with poorly characterized molecular function.
The genome of the yeast Saccharomyces cerevisiae encodes one member of the M14 MCP family, a pseudoenzyme
named Ecm14 proposed to function in the extracellular matrix. In order to better understand the function of such
pseudoenzymes, we studied the structure and function of Ecm14 in S. cerevisiae.
Results: A phylogenetic analysis of Ecm14 in fungi found it to be conserved throughout the ascomycete phylum,
with a group of related pseudoenzymes found in basidiomycetes. To investigate the structure and function of this
conserved protein, His6-tagged Ecm14 was overexpressed in Sf9 cells and purified. The prodomain of Ecm14 was
cleaved in vivo and in vitro by endopeptidases, suggesting an activation mechanism; however, no activity was
detectable using standard carboxypeptidase substrates. In order to determine the function of Ecm14 using an
unbiased screen, we undertook a synthetic lethal assay. Upon screening approximately 27,000 yeast colonies,
twenty-two putative synthetic lethal clones were identified. Further analysis showed many to be synthetic lethal
with auxotrophic marker genes and requiring multiple mutations, suggesting that there are few, if any, single S.
cerevisiae genes that present synthetic lethal interactions with ecm14Δ.
Conclusions: We show in this study that Ecm14, although lacking detectable enzyme activity, is a conserved
carboxypeptidase-like protein that is secreted from cells and is processed to a mature form by the action of an
endopeptidase. Our study and datasets from other recent large-scale screens suggest a role for Ecm14 in processes
such as vesicle-mediated transport and aggregate invasion, a fungal process that has been selected against in
modern laboratory strains of S. cerevisiae.
Keywords: Saccharomyces cerevisiae, Fungi, Protease, Carboxypeptidase, Prodomain, Pseudoenzyme, Synthetic lethal
assay, Cell wall, Extracellular matrix
Background
Most major enzyme families contain inactive enzyme
homologs, or pseudoenzymes. Pseudoenzymes are char-
acterized by highly conserved domains that are structur-
ally similar to their catalytically active homologs, but
with substitutions within key motifs suggesting a loss of
catalytic function [1, 2]. Research is just now beginning
to show the large part that these proteins play in biology;
they are much more than just innocent bystanders [3].
Pseudoenzymes have been shown to play key roles as
allosteric modulators and non-catalytic competitors in a
variety of signal transduction pathways [2].
Enzyme families in which pseudoenzymes have been
particularly well-characterized include kinase and prote-
ase families [4–6]. For example, within kinase families,
the pseudokinase FAM20A has been shown to allosteri-
cally activate its homolog, FAM20C, to enable increased
phosphorylation of secreted enamel proteins [7]. An-
other pseudokinase, vaccinia-related kinase 3 (VRK3),
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also works through allosteric activation, but the
activation of a phosphatase, resulting in inhibition of
extracellular-regulated kinase (ERK) activity and its pro-
liferative effects [8]. Within protease families, a number
have also been shown to be pseudoenzymes. For ex-
ample, the pseudoenzyme iRhoms regulate proteasomal
degradation and are necessary for the translocation of
the ADAM17 metalloprotease so that it can cleave the
TNFalpha precursor [6, 9]. Inactive ADAMs 11, 22, and
23 serve as receptors for the secreted neuronal protein,
LGI1; when ADAM22 is mutated it leads to a form of
epilepsy [10, 11].
The M14 family of metallocarboxypeptidases (MCPs)
is involved in trimming C-terminal amino acids from
substrate proteins and peptides, including neuropeptides,
clotting factors, and dietary peptides [12, 13]. This family
of proteases has been studied for nearly 100 years due to
the abundance of some members within the pancreas; as
such, we know a great deal about the catalytic and regu-
latory mechanisms of these enzymes [14, 15]. The M14
MCP family is typically divided into three subfamilies,
based on structural similarities. The pancreatic enzymes
are members of the A/B subfamily, most of which are
secreted and activated upon removal of a prodomain
[16–18]. A number of MCPs, of the N/E subfamily, are
either secreted or function within the secretory pathway,
where they function in the maturation of a variety of
peptide hormones and neuropeptides [19–21]. The
remaining members of this family are the cytosolic car-
boxypeptidases, which are important in regulating the
activity of microtubules within the cytoplasm [22–24].
Included within the approximately 23 members of
this enzyme family in mammals are several predicted
pseudoenzymes, carboxypeptidase X1 (Cpxm1) [25],
carboxypeptidase X2 (Cpxm2) [26], AE-binding pro-
tein 1 (Aebp1) [27, 28], and the third domain of car-
boxypeptidase D (CPD) [29] (Fig. 1a). While Cpxm1,
Cpxm2, and Aebp1 are all closely related and have
been found in recent years to be involved in connect-
ive tissue biology [30, 31], the function of the third
domain of CPD is unclear at this time. It is not un-
important, however, as it has been shown that this
third domain of CPD is necessary for full rescue of
an inviable Drosophila CPD deletion [32].
The yeast Saccharomyces cerevisiae, a common model
for eukaryotic cell biology, encodes only one member of
the M14 MCP family within its genome (Fig. 1b). This
gene is named extracellular mutant 14 (ECM14;
YHR132c in the systematic nomenclature) due to its
identification in a screen for genes involved in cell wall
integrity, specifically a sensitivity to calcofluor white
[33]. The Ecm14 protein is structurally similar to the A/
B subfamily of MCPs, and is predicted to be a pseudoen-
zyme, as a number of active site residues critical for
function of MCPs are substituted; residues involved in
the coordination of the C-terminus of a substrate pro-
tein or peptide are substituted (N144D and R145H,
using bovine CPA1 numbering that is typically used in
the field), and, most notably, the glutamic acid that
serves in acid-base catalysis, at position 270 in bovine
CPA1, is replaced with a lysine (Fig. 1a, d).
The specific function of Ecm14 is unknown, as is its
conservation throughout the fungal kingdom. In the
current study, we set out to characterize the function of
Ecm14, to shed further light on the function of this pro-
tein and the function of other pseudoenzymes within
this MCP class of enzymes. We show that Ecm14 is con-
served across a wide range of ascomycete fungi and can
be processed by trypsin-like enzymes to remove the pro-
domain. Using yeast genetics we show that few, if any,
single yeast genes in S. cerevisiae share synthetic lethal
interactions with the gene deletion, ecm14Δ, suggesting
either the presence of many redundant pathways or a
function unnecessary within the context of typical la-
boratory strains of S. cerevisiae.
Results
Ecm14 is the only member of the M14 metallocarboxy-
peptidase family found in the S. cerevisiae yeast. Ecm14
appears to be a pseudoenzyme, exhibiting substitutions
at several key catalytic residues (see Fig. 1a,d). We set
out to determine the function of Ecm14 through the use
of biochemical and genetic approaches.
Phylogenetic analysis of fungal Ecm14
We first took a bioinformatics approach to understand
the role of Ecm14. All fungal proteins within the NCBI
database were searched (June 2019) using BLASTp for
homology to bovine CPA1. This resulted in a dataset of
2066 sequences, after the deletion of sequences shorter
than 150 amino acids or those lacking the majority of
the carboxypeptidase domain. A phylogenetic tree was
inferred by maximum likelihood using IQ-TREE with
1000 bootstrap replicates, and the consensus tree pre-
sented with bovine CPA1 as the root of the tree (Fig. 2;
see also Additional files 1 and 2 for .nexml phylogenetic
tree data files for both the consensus and maximum
likelihood trees).
Protein sequences generally fell into three large
groups, CPA-like, CPB-like, and Ecm14-like proteins
(Fig. 2). Strong bootstrap support was obtained for most
major branchpoints of this tree, except for the node
between the major CPA and Ecm14 groups. This likely
reflects weak support for the position of the CPA and
Ecm14 sequences from the basal fungi. This ambiguity is
further supported by the fact that the active site residues
from these basal fungi enzymes are not at all different,
all exhibiting CPA-like character. CPA-like enzymes are
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Fig. 1 The M14 metallocarboxypeptidase family includes several predicted pseudopeptidases. a The amino acid sequences of two active
M14 metallocarboxypeptidase enzymes, CPA1 and CPE, were aligned with the sequences of several predicted pseudoenzymes of the M14
family using Clustal Omega. The sequences of the carboxypeptidase domains only are shown. Amino acids considered critical active site
residues within M14 carboxypeptidases are shown in red, with the corresponding numbering from mature bovine CPA1 shown above.
Blue background shading indicates increasing levels of sequence conservation from light to dark. Numbers on left and right indicate
amino acid number within the complete protein. b A three-dimensional model for S. cerevisiae Ecm14, with the prodomain shown in
blue and the carboxypeptidase-like domain shown in green. A coordinated zinc is modeled as a red sphere, and the arginine at which a
tryptic-like enzyme may cleave is shown in stick representation. c The active site of bovine CPA1 is compared with the corresponding
amino acids within S. cerevisiae Ecm14 (d)
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predicted to cleave aliphatic or aromatic C-terminal
amino acids due to a hydrophobic amino acid at the bot-
tom of their specificity pocket (residue 255 in bovine
CPA1), while CPB-like enzymes are predicted to cleave
basic C-terminal amino acids with an acidic amino acid,
often aspartic acid, at their residue 255 equivalent [18].
Fungal proteins identified within the CPB clade often
had an Asp at position 255; however, a lot of variation
Fig. 2 Ecm14 is conserved in Ascomycota, but not in other fungal phyla. BLASTp was performed with bovine CPA1 as the query sequence and
all fungal sequences as the search set. Two thousand sixty-six sequences of 150 amino acids or longer that contained the majority of the
carboxypeptidase domain were identified using Clustal Omega and the best maximum likelihood phylogenetic tree inferred using IQ-TREE.
Branch support was determined by 1000 ultrafast bootstrap replicates, and bootstrap support values are shown at key nodes. The resulting tree
contains three predominant groups consistent with CPB-like, CPA-like, and Ecm14-like properties. The identities of these groups are demonstrated
by the active site residues found in all metallocarboxypeptidases (shown in black on the right) and unique variants (red; particularly at position
255) that often define the subclass. On the phylogenetic tree, sequences from basal (monokaryotic) fungi are shown in pink. CPB sequences from
ascomycetes are shown in red, with co-clustering sequences lacking the required Asp at position 255 shown in a darker red. CPA-like sequences,
mostly from ascomycetes, are shown in blue. Ecm14 sequences, all from ascomycetes, are shown in dark green. A sister clade of Ecm14-like
proteins from basidiomycetes, and with unique and conserved ‘active’ site residues, is shown in lighter shades of green. Ecm14 proteins are
defined by the presence of N144D and E270K substitutions
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was seen at this position, as nearly every amino acid was
represented. Similar results were observed in the CPA
clade; while most proteins had a hydrophobic amino
acid at position 255, many other amino acids were found
to occupy this position also. Notably, no CPB sequences
were found in Basidiomycota, and only 24 of 766 se-
quences in the CPA group were from Basidiomycota.
Because a number of sequences from each of these three
major groups (CPA-like, CPB-like, and Ecm14-like) were
identified from organisms traditionally called the basal
fungi or the monokaryotic fungi (eg. Chytridiomycota
and Zygomycota) [34], it seems most likely that the CPA
and CPB genes have been lost in most members of the
basidiomycete clade.
The Ecm14 clade was the largest of the three, similar
to the CPA clade in number of sequences but far ex-
ceeding it in terms of species representation (479 species
for Ecm14 versus 219 species for CPA; Fig. 2). All
Ecm14 sequences were derived from ascomycete fungi
and were strictly defined by the presence of Asp at pos-
ition 144 and Lys at position 270. Active metallocarbox-
ypeptidases have a conserved Asn at position 144, which
is involved in substrate binding, and a critical Glu at
position 270 which serves as a proton donor and ac-
ceptor in general acid-base catalysis [14].
A large group of CP-like proteins from Basidiomycota
were identified as a sister clade to Ecm14, in which the
active MCP Asn144 was conserved. However, in about
half of these sequences, Arg145 was replaced with a Ser,
likely resulting in the inability to bind the carboxyl
group of a substrate. In the other half of these se-
quences, three active site substitutions were found:
Arg127Tyr, His196Arg, and Glu270His (Fig. 2). Arg127
typically functions in binding of the scissile carboxyl
group during cleavage, while His196 coordinates the zinc
ion cofactor of active enzymes and, of course, Glu270 is
necessary for acid-base catalysis. The presence of substi-
tutions at these important residues suggests that these
proteins are also inactive enzymes.
Altogether, these results suggest that Ecm14 is a
widely-distributed protein within the ascomycete branch
of the fungal kingdom with unique active site residues
that are conserved and thus likely to be functional.
Ecm14 purification and biochemical analysis
In order to determine whether Ecm14 was functional as a
carboxypeptidase enzyme or as a pseudoenzyme, we
attempted purification by metal-affinity chromatography.
Histidine-tagged Ecm14 was expressed in its native envir-
onment, the yeast S. cerevisiae, under the control of a
galactose-inducible promoter from the plasmid pEM-
BLyEx4. This resulted in abundant Ecm14-His6 expres-
sion, typically observed as a doublet approximately 45 kDa
in size (pro-Ecm14) and another doublet at 35 kDa
(mature Ecm14), as detected by anti-His6 western blotting
(Fig. 3a). The two doublets were due to N-glycosylation of
Ecm14, confirmed by a reduction of doublets to singlets
upon incubation with EndoH (Fig. 3a). N-glycosylation
was predicted at two sites by NetNGlyc, both sites found
on the surface of Ecm14 (Fig. 3b,c).
Ecm14-His6 protein overexpressed in yeast was mostly
insoluble and was not able to be purified even following
denaturation in urea or guanidine. In contrast, when
Ecm14-His6 was expressed in the Sf9 insect cell system
using a baculovirus expression vector, about 50% of
Ecm14-His6 protein was secreted into the media in
soluble form by 3 days post-infection, typically as a
doublet at 45 kDa (see Additional file 1: Figure S1A). A
small amount of this 45 kDa protein was processed to
produce a 35 kDa protein in Sf9 cells (see Add-
itional file 3: Figure S1A), suggesting the removal of the
prodomain. Addition of trypsin or chymotrypsin to con-
ditioned media converted the large majority of 45 kDa
protein to the 35 kDa form, and also greatly enhanced
the purification of Ecm14-His6 by metal-affinity chro-
matography (see Additional file 3: Figure S1B-D).
The observation that Ecm14 could be processed into a
smaller form by endopeptidase digestion both in vivo and
in vitro suggested possible prodomain removal, and that
this cleavage may be necessary for full activity of Ecm14.
To investigate this maturation process further, Ecm14-
His6 within conditioned Sf9 media was digested with tryp-
sin and chymotrypsin. Digestion with 5 μg/ml chymotryp-
sin showed the reaction to be complete after 40min at
room temperature, with at least two products observed at
about 35 kDa. Optimal cleavage by 5 μg/ml trypsin was ob-
served after only 1–5min, with one distinct band observed
at 35 kDa (Fig. 4a). To identify the sites of cleavage, Edman
degradation was performed on purified Ecm14-His6 fol-
lowing cleavage by either chymotrypsin or trypsin. It was
found that chymotrypsin cleaved at 3 locations within the
linker region between the prodomain and the carboxypep-
tidase domain, while trypsin cleaved only once, C-terminal
to an arginine in this same region (Fig. 4b, c, see Add-
itional file 3: Figure S2). The much cleaner and more rapid
digestion by trypsin suggested that a trypsin-like enzyme
might be important for full Ecm14 activity in vivo.
Purified Ecm14-His6 was incubated with standard car-
boxypeptidase substrates (3-(2-Furyl)acryloyl-Phe-Phe,
-Phe-Ala or -Glu-Glu) at 0.5 mM and at a range of pH
values from 5.5 to 7.5. No activity was detected under
any of these conditions, even though the prodomain was
no longer present.
Biological function of Ecm14 through targeted genetic
analyses
A number of large-scale screens in yeast have suggested
possible functions for Ecm14. Ecm14 was first identified
McDonald et al. BMC Molecular and Cell Biology           (2020) 21:86 Page 5 of 16
in a large screen searching for mutations leading to sen-
sitivity to calcofluor white, suggesting a cell wall defect
[33]. We have not been able to clearly replicate this
phenotype. While a slight sensitivity to calcofluor
white was observed upon deletion of the ECM14 gene
(ecm14Δ) in the BY4741 MATa strain (see Additional
file 3: Figure S3A), an ecm14Δ deletion in the same
strain stored independently in another lab did not
result in the same sensitivity (see Additional file 3:
Figure S3B).
Hillenmeyer et al. attempted to tease out the functions
of nonessential yeast genes through a large-scale screen
in which they measured the fitness of yeast mutants
upon incubation with a variety of chemicals or in various
Fig. 3 Ecm14 is N-glycosylated and processed by an endopeptidase in S. cerevisiae. a Yeast extracts that overexpressed Ecm14-His6 were
incubated with endoglycosidase H (EndoH) and analyzed by western blotting with an anti-His6 antibody. ProEcm14 observed as a broad band at
45 kDa (likely two bands) collapses to one thin band with EndoH, and mature Ecm14 observed as two bands at 35 kDa collapses to one. b
NetNGlyc 1.0 predicts there to be two N-glycosylation sites within Ecm14, on asparagines at positions 41 within the prodomain and 295 within
the carboxypeptidase domain. c These asparagines, shown as yellow spheres, are both located on the surface of the Ecm14 homology model.
The prodomain of Ecm14 is shown in blue, the carboxypeptidase-like domain in green, and a coordinated zinc is modeled as a red sphere
Fig. 4 The prodomain of Ecm14 can be cleaved by chymotrypsin and trypsin enzymes. a Media containing proEcm14-His6 secreted from
baculovirus infected Sf9 cells was digested with chymotrypsin or trypsin for the indicated times and analyzed by Western blotting with an anti-
His6 antibody. b Following this digest, the resulting mature protein was purified by metal-affinity chromatography and N-terminally sequenced
by Edman degradation. Results of the first round of sequencing are shown. c Sites of cleavage, as shown by Edman degradation, within the
region of Ecm14 linking the prodomain and the carboxypeptidase-like domain, are indicated by arrows
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environmental conditions [35]. Decreased fitness was
observed for ecm14Δ cells under a number of condi-
tions. We incubated wild-type and ecm14Δ yeast in YPD
media supplemented with many chemicals that were
shown by Hillenmeyer et al. to effect fitness, including
paraquat (5 mM), miconazole nitrate (25, 50, and 100
µM), alverine citrate (500 µM), hydrogen peroxide (2
and 5mM), D-sorbitol (0.75 and 1.5M), mercury (II)
chloride (15.6 and 62.5 µM), and lithium chloride (150
and 300 mM). Of these, a small and reproducible effect
was observed for lithium chloride only, that being a
small increase in ecm14Δ cell growth rate compared to
wild-type cells (see Additional file 3: Figure S3C).
Other reports have described a number of genetic syn-
thetic lethal phenotypes. For example, yeast with arp1Δ
deletions were shown to be inviable together with an
ecm14Δ mutation [36]. Our attempts to replicate this re-
sult also came up empty-handed. Our BY4741a yeast
with both ecm14Δ and arp1Δ deletions remained viable.
Biological function of Ecm14 through synthetic lethal
genetic analysis
In lieu of any clearly identifiable phenotype for ecm14Δ
cells, we sought to identify the function of ECM14
through a synthetic lethal approach, in which the lethal-
ity of two gene mutations is rescued by expression of
one wild-type gene from a plasmid. While many genes
putatively synthetic lethal with the ecm14Δ gene have
been listed in the yeast database (yeastgenome.org) from
large genome-wide screens in recent years, many of
these putative genetic interactions do not exceed default
Pearson correlation coefficient thresholds (see thecell-
map.org), and so we reasoned that a synthetic lethal ex-
periment targeted specifically at ecm14Δ would provide
better-validated data. Therefore, ecm14Δ cell suspen-
sions, transformed with pSLS1-ECM14, were treated
with ethyl methanesulfonate (EMS) and plated on rich
media containing galactose to destabilize the pSLS1-
ECM14 plasmid (see Additional file 3: Figure S4 for a
map of this plasmid). Those yeast acquiring secondary
mutations requiring the ECM14 gene for viability would
maintain the plasmid and would be identified due to red
pigmentation produced by the ADE3 gene on the plas-
mid (Fig. 5a). Yeast not requiring the plasmid for viabil-
ity would rapidly lose it, resulting in white or sectored
colonies. YPD plates were used as controls to determine
the effectiveness of EMS mutagenesis and to tune EMS
exposure time. An EMS exposure time of 45 min was
determined to be effective at generating the ideal cell
death (~ 40%; (Winston, 2008)) in the yeast strains used
in this study (see Additional file 3: Figure S5).
Because the pSLS1-ECM14 plasmid contains two add-
itional yeast genes (ADE3 and URA3), this approach
could also identity false-positive synthetic lethals caused
by a dependency on either the plasmid-borne ADE3 or
URA3 genes. Effectively silencing either the ADE3 or
URA3 gene could potentially improve the sensitivity of
the synthetic lethal screen and decrease the number of
false-positives to be subsequently evaluated. Because the
URA3 gene was not involved in the synthetic lethal
screen, a modification was made in later experiments in
which YPGal media containing extra uracil (0.001%) was
used to decrease undesirable URA3 false-positives. In
addition, a modified YPGal medium containing 20 μg/ml
calcofluor white was also used for screening EMS-
treated cells. Exposure to calcofluor white (CFW) ampli-
fies the effect of mutations in genes involved in cell wall
architecture and remodeling [33], and therefore it was
thought that CFW might increase the sensitivity of the
synthetic lethal screen to novel mutations in genes
functionally related to ECM14. An active, plasmid-borne
ADE3 gene was required for the ADE3/ADE2 color assay
essential to the synthetic lethal screen. Therefore,
modifications to decrease ADE3 false-positives were not
made.
Approximately 27,000 EMS-treated ecm14Δ [pSLS1-
ECM14] yeast colonies were screened for novel plasmid
dependencies on galactose media (either YPGal, YPGal+
CFW, or YPGal+Ura + CFW). Three rounds of EMS mu-
tagenesis were performed, with each yielding approxi-
mately 9000 screenable EMS-treated yeast colonies.
Colonies of interest were those that produced the de-
sired non-sectored red phenotype on these media. These
non-sectored red colonies of interest were re-streaked
for single colonies on fresh media to further evaluate the
development and the maintenance of the desired non-
sectored red phenotype (Fig. 5b). The first round of
EMS mutagenesis yielded five putative synthetic lethal
mutants (SL1–5) derived from YPGal. The second round
yielded two putative synthetic lethal mutants derived
from YPGal+Ura + CFW (SL6–7) and seven from YPGal
(SL8–14). The final round yielded eight putative syn-
thetic lethal mutants derived from YPGal+Ura and
YPGal+Ura + CFW (SL15–22). SL10, 11, and 13 were
unique in that they did not retain their red color when
plated onto YPGal containing calcofluor white. Some
colonies of interest, particularly SL 9, 10, and 13, that
initially produced the desired non-sectored red pheno-
type on these media following EMS treatment, produced
a mosaic phenotype when re-streaked on galactose
media, suggesting that they may not be true synthetic
lethals.
Additional rounds of growth on both SC-Ura and SC +
5FOA were attempted to test for true synthetic lethal
mutants caused by novel secondary mutations or for po-
tential false-positives caused by reversions of marker
genes. Counterselection against the plasmid-borne
URA3 gene using 5FOA should result in plasmid loss
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and, thus, cell death for true synthetic lethal mutants.
This test was performed on the first five putative syn-
thetic lethal mutants (SL1–5; see Additional file 3: Fig-
ure S6). Although these five putative synthetic lethal
mutants seemed to retain the desired phenotype when
subsequently re-plated/spotted on YPGal, all five were
unable to grow appreciably on any SC-based media.
However, because the EMS-treated white non-synthetic
lethal colony (ecm14Δ) and untreated control strain
(ecm14Δ [pSLS1-ECM14]) were able to grow on SC-
based media, the apparent lack of growth of these
synthetic lethal mutants seemed to be the result of
secondary mutations conferring significant fitness defi-
ciencies on SC-based media.
Synthetic lethal mutants were further analyzed to con-
firm synthetic lethality with ecm14Δ (Fig. 6). Mutants
were crossed with wild-type yeast of an isogenic back-
ground, containing a plasmid (pRS316-NatMX) allowing
growth on nourseothricin, and heterozygous diploids
were selected by growth on YPD + G418 + nourseothri-
cin. Diploid colonies were grown on SC + 5FOA to elim-
inate plasmids, and then transformed with pSLS1 or
pSLS1-ECM14. Sporulation of diploids was performed
and random spores germinated on YPGal plates. The
Fig. 5 The synthetic lethal assay used to identify novel mutant yeast whose survival was dependent on the ECM14 gene. a (1) Wild-type ECM14 was
first moved from the yeast genome into the pSLS1 vector (pSLS1-ECM14). (2) Random genomic point mutations were introduced throughout the
yeast genome using ethyl methansulfonate (EMS). (3) Colonies dependent on ECM14 were identified as non-sectored red colonies. b Putative
synthetic lethal mutants that initially produced the desired non-sectored red phenotype were re-streaked for single colonies on galactose media to
evaluate the development and maintenance of the red phenotype. Asterisks indicate colonies that were screened on media containing Ura + CFW
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percentage of unsectored red colonies was determined,
and compared to expected segregation of the phenotype.
If only two mutations were required for the red synthetic
lethal phenotype (ie. the ecm14Δ mutation and mutation
of one additional gene by EMS), then we would expect
approximately 1/4 of spores derived from a heterozygous
diploid to be red. If two EMS mutations were required
for synthetic lethality, then approximately 1/8 of spores
would be red, and so on.
An average of 204 germinated spores were analyzed
per synthetic lethal clone. Nine of 16 synthetic lethal
clones were rescued by the pSLS(−) plasmid itself, indi-
cating synthetic lethality with another element on the
plasmid (Table 1). In these cases, the fraction of total
colonies being red suggested that 1–3 EMS mutations
were required for the synthetic lethality. Very few, if any,
red colonies were observed for the remaining seven
clones, suggesting that these were either not true syn-
thetic lethals, or that four or more EMS mutations were
required to generate the synthetic lethality, and, there-
fore, that useful genetic information would be difficult
to identify (Table 1).
Identification and analysis of ECM14 interacting genes
ECM14 interacting genes were analyzed in two ways.
First, all genes reported within the Saccharomyces gen-
ome database (SGD) to interact either physically or
genetically with ECM14 were submitted for Gene Ontol-
ogy (GO) analysis. The top reported GO function and
process terms, found to be enriched in this gene list
compared with all yeast genes (p < 0.05) included terms
such as vesicle-mediated transport, lipid binding, and or-
ganelle organization (Fig. 7). About 40% of interacting
genes shared the term endomembrane system. These
terms are consistent with a secreted or secretory role for
ECM14 in cell wall maintenance. Genes reported in the
SGD to physically or genetically interact with ADE3 or
URA3 were also assessed by GO analysis. This GO ana-
lysis was performed in order to compare ADE3 and
URA3 interacting genes with those mutated in our syn-
thetic lethal assay, to further determine likely relevance.
Seven putative synthetic lethal mutants (SL6, SL7, SL8,
SL11, SL12, SL13, and SL14) were selected for whole-
genome sequencing using the Illumina MiniSeq plat-
form. Clones were chosen for a diversity of red color
phenotypes prior to the above complementation analysis.
Sequencing resulted in 30-50x coverage (Table S1) and,
after elimination of noncoding and silent variants when
compared to the WT sequence, 46–123 variants were
identified for each synthetic lethal clone. Because this
was too many to be useful, further analysis was per-
formed in PROVEAN to identify those variants likely to
be deleterious, using a stringent cutoff of − 4.0. GO ana-
lysis was performed on these gene lists. For all clones
Fig. 6 The functional rescue assay workflow. (1) A diploid yeast strain is produced by crossing a wild-type haploid [pRS316-NatMX] strain with a
haploid synthetically lethal strain (gene-y, ecm14::KanMX). Diploids are selected for by growth on YPD/G418/NTC. (2) Growth on SC + 5FOA allows
for selection against the now unnecessary pRS316-NatMX and pSLS1-ECM14 plasmids. (3) Cells are transformed with the pSLS1 or pSLS1-ECM14
plasmids followed by (4) random sporulation and germination of these haploid spores on YPGal
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except SL7 and SL13, some enrichment (although not al-
ways reaching significance, p < 0.05) was found for GO
terms associated with ADE3 interacting genes. Very few
of the GO terms identified for remaining synthetic lethal
gene mutations reached a p < 0.05 level of significance.
In some cases, missense mutations were identified in
genes known to be synthetic lethal with ade3. For ex-
ample, both SL6 and SL7 presented very consistently red
synthetic lethal colonies; a mutation in the SHM2 gene
resulting in a D219N amino acid change was identified
in both (Table 1). Likewise, SL11 and SL14 contained
mutations in the SHM2 gene, while SL13 contained a
mutation in the SHM1 gene. Both the SHM1 and SHM2
genes are reported in the SGD to be synthetic lethals of
the ade3 gene. These results are consistent with the res-
cue of SL6, SL7, SL11, and SL14 by the pSLS(−) plasmid,
suggesting that the mutations in these clones leading to
synthetic lethality are mutations within the ADE3 or
URA3 pathways rather than within ECM14 interacting
genes.
Two of the synthetic lethal clones that were se-
quenced, SL12 and SL13, were not rescued by the
pSLS(−) plasmid (see Table 1), and the results of this
rescue experiment suggested that 4 or more mutations
were involved in this phenotype. A careful GO analysis
of the 36 genes mutated in SL12 and SL13 having PRO-
VEAN scores of less than − 4.0 resulted in the gene
ontology terms (p < 0.05) lyase activity and adenylate cy-
clase activity, in addition to the more general terms
small molecule binding, cofactor binding, and catalytic
activity. The five genes fitting the categories of lyase and
adenylate cyclase activities were PXP1, encoding a per-
oxisomal protein, SOG2, encoding a signaling protein in-
volved in cell morphogenesis and cytokinesis, ILV3,
encoding an enzyme involved in amino acid biosyn-
thesis, CYR1, encoding adenylate cyclase necessary for
cAMP production, and HSP31, encoding an enzyme in-
volved in oxidative and DNA replication stress. None of
these have been previously identified as interacting with
ECM14, and it is difficult to identify a theme that might
connect these to ECM14 function.
Discussion
Fungi necessarily rely on a wide variety of hydrolases to
break down and absorb the materials on which they
grow. Few studies have examined carboxypeptidases
expressed by fungi. To our knowledge, only two asco-
mycete metallocarboxypeptidases have been previously
identified and characterized: several publications have
examined one carboxypeptidase A (CPA) from Metarhi-
zium anisopliae [37–39], while a second related CPA
from Trichophyton rubrum had also been partially char-
acterized [40]. Both enzymes exhibited typical CPA-like
substrate specificity.
It is likely that Ecm14 is an inactive enzyme, or pseu-
doenzyme. Although it is difficult, if not impossible, to
prove the absence of a function, we have been unable to
detect carboxypeptidase activity in S. cerevisiae Ecm14
using standard chromogenic assays, and this is
Table 1 Analysis of isolated synthetic lethals
Name pSLS1(−) rescue (% red colonies) pSLS-ECM14 rescue (% red colonies) # of causative mutations Possible causative mutationa
WT 0 0 – –
SL1 3.9 2.7 3 ND
SL2 0 0 ≥4 ND
SL4 0 0 ≥4 ND
SL6 16.8 (1/6) 20.6 (1/5) 1 SHM2 D219N (ade3 SL)
SL7 21.0 (1/5) 18.5 (1/5) 1 SHM2 D219N (ade3 SL)
SL8 7.7 0 3
SL9 0 1.5 ≥4 ND
SL10 0 0 ≥4 ND
SL11 10.5 (1/10) 10.6 (1/10) 2 SHM2 G403R (ade3 SL)
SL12 0 0 ≥4
SL13 0 0.8 ≥4 SHM1 P252S (ade3 SL)
SL14 6.9 8.9 2 SHM2 G252D (ade3 SL)
SL15 15.0 9.1 2 ND
SL18 0 0 ≥4 ND
SL20 5.0 0 3 ND
SL21 15.1 7.6 2 ND
a ND not determined
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Fig. 7 Gene Ontology (GO) analysis of genetic interactors. a Genes annotated by the Saccharomyces genome database (SGD) as interacting either
physically or genetically with ADE3, ECM14, or URA3 were analyzed by Gene Ontology (GO). Little overlap is observed between GO terms for these
three genes. The heatmap represents P-values for enrichment of genes within particular GO classifications. Arrowhead next to heatmap scale bar
indicates 0.05. Top 25 GO terms are shown for ECM14 only. b GO analysis for genes identified by whole-genome sequencing as being mutated in
the indicated synthetic lethals, and for which PROVEAN analysis surpassed a threshold of − 4.0. GO terms are mapped to those identified in the
SGD for ADE3, ECM14, and URA3 interactors. All others are listed at ND, not determined
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consistent with the substitution of critical residues
within the pseudoactive site of Ecm14 (Fig. 1).
ECM14 was previously identified through transposon
mutagenesis as a gene providing resistance to calcofluor
white and thus implicated in cell wall maintenance [33].
The ecm14 mutant, in addition to being sensitive to cal-
cofluor white, exhibited an increased mannose:glucose
ratio and was sensitive to the effects of the aminogly-
coside antibiotic hygromycin B and the glycolipid
papulacandin B, thought to inhibit β1,3-glucan syn-
thesis [33]. In this study of cell wall maintenance, two
yeast strains with differing sensitivity to calcofluor
white were used, and the ecm14 mutant was only
identified in one of these two screens. This differing
sensitivity is consistent with our observation of strain-
specific sensitivities, as mild calcofluor white sensitiv-
ity was only detected in BY4741a ecm14Δ cells grown
long-term in one of two labs.
An understanding of the subcellular or extracellular
location of a protein such as Ecm14 can provide useful
information regarding the biological function of the pro-
tein. In our study, although we were unable to identify
Ecm14 in the liquid growth media of S. cerevisiae cells
expressing Ecm14-His6 (not shown), Ecm14-His6 was
secreted when expressed heterologously from Sf9 cells
(see Additional file 3: Figure S1). Others have shown
differing results regarding localization. One large-scale
analysis of yeast GFP-fusion proteins found that Ecm14-
GFP was localized to the yeast vacuole [41]. When the
SPELL (Serial Pattern of Expression Levels Locator)
search engine [42] is queried for genes with expression
profiles similar to ECM14, the top hits indicate GO term
enrichment for the vacuole. A proteomic analysis of S.
cerevisiae grown in biofilm-like mats identified Ecm14 as
one of many proteins found in the extracellular matrix,
but not secreted into the medium of a liquid culture
[43]. These results suggest that Ecm14 likely functions
within the extracellular matrix of yeast, maybe under
biofilm-like conditions primarily, or possibly within the
vacuole for the intracellular regulation of cell wall and
extracellular matrix components.
Ecm14 has been identified in studies of several patho-
genic fungi in recent years, and these studies continue to
point toward a function in cell wall/extracellular matrix
remodeling. A C. albicans screen for genes involved in
aggregate invasive growth, a process related to biofilm
formation, identified an ECM14 mutant showing fewer
aggregates than the wild-type [44]. This hints at a role in
aggregate invasion, although the equivalent experiment
performed in S. cerevisiae of the Σ1278b background,
which can undergo aggregate invasive growth, did not
result in a phenotype [44], suggesting either a false posi-
tive in the first screen or the use of inappropriate condi-
tions for this assay with S. cerevisiae. A transcriptomics
study of the plant pathogen Verticillium dahliae showed
that the expression of Ecm14, along with a variety of cell
wall degrading hydrolases, was upregulated in response
to exudates from V. dahliae-susceptible cotton roots
[45]. This again points to a possible role for Ecm14 in
invasion. Finally, a recent analysis of glycosylation in the
plant pathogen M. oryzae showed that the glycosylation
of Ecm14 is upregulated primarily during mycelial
growth as compared with the conidia and appressoria
stages [46]. It was proposed that many proteins differen-
tially glycosylated during mycelial growth were involved
in cell wall biogenesis and nutrient utilization [46]. Our
study found that Ecm14 expressed in S. cerevisiae was
also glycosylated, although we did not examine the func-
tion of this modification (Fig. 3).
The molecular details of fungal invasion are important
to understand as we try to counteract the pathogenic ef-
fects of many fungi. The above studies indicating a role
for Ecm14 in fungal growth and pathogenesis lend sup-
port to our study in which we show that Ecm14 is highly
conserved across the ascomycete lineage (see Fig. 2). An
analysis of all reported interactions with ECM14 sup-
ports the likelihood that a functional secretory pathway
and other aspects of organellar trafficking are required
for Ecm14 function. Unfortunately, our specific attempts
to further identify redundant pathways through a syn-
thetic lethal approach suggested that redundant path-
ways were many, such that we were unable to isolate a
single-gene synthetic lethal clone from the analysis of
nearly 30,000 mutants, or that Ecm14 was not required
in the conditions and cells examined in this synthetic le-
thal assay. It could be that a clear phenotype for S. cere-
visiae ecm14Δ mutants has not yet been identified
because most yeast that are used in the lab are unable to
effectively form aggregates. Scientists have effectively se-
lected against this phenotype to make yeast genetics
simpler.
Conclusions
Our data suggest that, while Ecm14 may not be required
in many laboratory strains of S. cerevisiae, Ecm14 is a
conserved and important pseudoenzyme within many
fungal species, that exists in zymogen form until acti-
vated by a trypsin-like endopeptidase, whereupon it
likely functions in cell wall maintenance and/or fungal
invasion. Notably, two vertebrate pseudoenzymes within
the M14 MCP family are also involved in extracellular
matrix functions, recently shown to bind collagen and
support the mechanical strength of connective tissues
[31, 47].
Methods
Bioinformatics – BLASTp was used to search for all fun-
gal proteins with homology to bovine CPA1. This
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dataset was further trimmed to remove short sequences
and a Python script used to edit FASTA names. Clustal
Omega [48] was used to create multiple alignments to
enable analysis of active site residues and Jalview [49]
was used for presentation of alignments. MEGA-X [50]
was used to find the best-fit amino acid substitution
model (WAG+G + F for our dataset), and this substitu-
tion model was used in IQ-TREE [51] to infer the best
maximum likelihood phylogenetic tree. Branch supports
were determined with an ultrafast bootstrap approxima-
tion with 1000 replicates in IQ-TREE. The SH-like ap-
proximate likelihood ratio test (aLRT) was also run with
1000 bootstrap replicates. Dendroscope [52] was used
for presentation of the resulting consensus phylogenetic
tree with bootstrap support values.
Structural modeling – The structural model for
Ecm14 was constructed using SWISS-MODEL [53], with
bovine procarboxypeptidase A1 (1PYT chain b) as tem-
plate. Images were prepared with Pymol.
Baculovirus packaging – Plasmid DNA (pVL1392-
Ecm14-His6; 50 ng) was mixed with 2.5 μl ProGreen
baculovirus DNA (AB Vector) and water to a total vol-
ume of 25 μl. Profectin (AB Vector; 2.5 μl) was mixed
with 22.5 μl water and added to the DNA mixture. Fol-
lowing a 20 min incubation, this was added to Sf9 cells
(ATCC CRL-1711), seeded the day before in a 25-well
dish at 2.5 × 105 cells per well in 250 μl Sf-900™ II
serum-free media (Thermo Fisher). Cells were checked
daily for GFP fluorescence to confirm infection. Virus
titer was amplified through several rounds of Sf9 infec-
tion to get a P3 stock.
Protein purification – Sf9 cells were infected at 2 × 106
cells/ml with P3 baculovirus stock at 1% of the total
volume. Conditioned media (typically 200–300 ml) was
collected 3 days post-infection. Trypsin was added at
0.5 μg/ml and incubated at room temperature (22 °C) for
15 min to cleave the Ecm14 prodomain. The trypsin re-
action was stopped by the addition of 1 mM phenyl-
methylsulfonyl fluoride (PMSF). A 1ml bed volume of
TALON metal affinity resin (Clontech) was washed
twice with 10ml wash buffer (50 mM sodium phosphate,
300 mM NaCl, pH 6.9) and added to conditioned media
to which an additional 200 mM NaCl had been added.
This was incubated at room temperature on a rocker
for 45 min, followed by a short centrifugation to col-
lect resin. The resin was washed twice in 10 ml wash
buffer, rocking for 10 min, then transferred to a col-
umn and further washed by gravity with 15 ml wash
buffer. Elution was performed by gravity with 5 ml
wash buffer containing 300 mM imidazole, collecting
0.5 ml fractions. Purified protein was quantified by
Bradford assay (Bio-Rad), and purity assessed by SDS-
PAGE followed by staining with Bio-Safe™ Coomassie
Stain (Bio-Rad).
Western blotting – Proteins were resolved by SDS-
PAGE on 10% gels and transferred to nitrocellulose.
Western blotting was performed according to standard
protocol with mouse anti-His6 primary antibody
(ThermoFisher, Clone HIS.H8; 1:2000 dilution) and
horseradish peroxidase-conjugated secondary antibody
(Cell Signaling Technology, 1:2000 dilution). Images
were obtained using LumiGLO chemiluminescent re-
agent (Cell Signaling Technology).
Glycosylation analysis – Protein extracts were incu-
bated with EndoH (NEB) in denaturing buffer and G5
reaction buffer for 1 h at 37 °C.
Carboxypeptidase enzyme assay – Ten to twenty
microliters of protein extract or purified protein were in-
cubated in a polystyrene 96-well plate with 0.5 mM
substrate (3-(2-Furyl)acryloyl-Phe-Phe, −Phe-Ala, or
-Glu-Glu; Bachem) in 50mM Tris, 50 mM NaAc, 150
mM NaCl, at pH 5.5 to 7.5. Absorbance at 340 nm was
read every minute for 30–60 min at 37 °C.
Edman degradation – Purified Ecm14-His6 (200 pmol)
was resolved by SDS-PAGE, transferred to polyvinyli-
dene difluoride membrane, and stained with Ponceau S.
Bands were cut out and membranes destained with
water. Six rounds of Edman degradation were performed
by the Synthesis & Sequencing Facility at Johns Hopkins
University.
Yeast culture – YPD media (10 g/l yeast extract, 20 g/l
peptone, 20 g/l dextrose) was used for the routine propa-
gation of yeast, supplemented when necessary with 8ml/
l of 0.5% (w/v) adenine (YPD + Ade), filter-sterilized Ge-
neticin® (G418 sulfate, 500 μg/ml), or filter-sterilized
nourseothricin sulfate (NTC, 100 μg/ml). Synthetic
complete (SC-Ura) media (1% succinic acid, 0.6% so-
dium hydroxide, 0.67% yeast nitrogenous base, 1% casa-
mino acids, 0.005% adenine, 0.002% tryptophan, 2%
dextrose) was used for plasmid selection. When neces-
sary, 0.001% uracil and 5-Fluoroorotic Acid (5FOA,
100X from Zymo Research) were added to SC media
media. YPGal media (10 g/l yeast extract, 20 g/l peptone,
20 g/l galactose) was used for the destabilization of yeast
centromere plasmids under the influence of the galact-
ose promoter.
Yeast strains – For most early experiments, BY4741
(ATCC # 201388; MATa (ura3–52 lys2–801 ade2–101
trpl-1 his3–200 TUB4::3XHA, URA3), a generous gift
from Melanie Dobson, Dalhousie University) yeast were
used. For the synthetic lethal experiment, ecm14Δ
knockouts (ecm14::KanMX) were made in the AF-1A or
AF-1D background (a modified W303 strain, ATCC
#208352 and 201,238; MATα and MATa, respectively;
ade2–1 ura3–1 leu2–3,-112 his3–11,-15 trp1–1 ade3Δ; a
generous gift from Melanie Dobson, Dalhousie Univer-
sity) by homologous recombination with the G418
cassette amplified from ecm14Δ cells of the yeast
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knockout collection (standard yeast transformation pro-
cedures) by PCR. Results were confirmed by PCR with
ECM14_A, ECM14_D, and Kan_C primers.
Synthetic lethal assay – Fresh monoclonal colonies of
AF-1D ecm14::KanMX [pSLS1-ECM14] were used to in-
oculate 10 ml of SC-Ura media. Following overnight cul-
ture, 2 × 108 cells were pelleted, washed twice in 1 ml of
sterile water, and resuspended in 1.5 ml of sterile sodium
phosphate buffer (0.1 M, pH 7.0). Ethyl methanesulfo-
nate (EMS) mutagenesis was performed by combining
0.7 ml of cell suspension, 1 ml of sodium phosphate buf-
fer, and 50 μl of EMS in a sterile 15-ml polypropylene
culture tube and incubating at 30 °C for 45–60 min. The
remaining cell suspension was saved on ice as a pre-
mutagenesis control. Mutagenesis was halted by adding
0.2 ml of EMS treated cells to a sterile culture tube con-
taining 8 ml of sterile sodium thiosulfate solution (5%).
Nonmutagenized control cells were diluted equivalently
as above by substituting EMS with sterile water. Both
EMS-treated and untreated cell suspensions were serially
diluted to 1–3 viable cells/μl for plating on various
growth media (100–300 viable cells per plate). The EMS
mutagenesis protocol used in this study was adapted
from Winston [54] and Barbour and Xiao [55].
Yeast sporulation – 1.5 ml 1% YPA (1% yeast extract,
2% peptone, 1% KAc) was inoculated with a single dip-
loid colony and grown in 15 ml culture tubes shaking ~
20 h at 30 °C. Cells were pelleted, washed with sterile
water, and 1.5 ml sporulation media (1% KAc) added.
Yeast were incubated at 250 rpm, 30 °C, for 7–10 days to
sporulate. Two μl of zymolyase (Zymo Research) was
added to 100 μl of the sporulation culture for 10 min,
which was then diluted and plated following vigorous
vortexing. As diploids do not maintain the plasmid on
YPGal, red colonies indicated haploid cells.
Plasmids – See Table S2 for a list of plasmids used in
this study. Plasmids were purified either using a Qiagen
miniprep kit according to the manufacturer’s instruc-
tions, or by the nonionic detergent method [56]. In
order to make pSLS-ECM14, the ECM14 sequence was
amplified by PCR with Platinum SuperFi® DNA Polymer-
ase (Invitrogen) from BY4741a genomic DNA using
ECM14_A and ECM14_D primers with included BamHI
restriction sites for cloning into pSLS1. The insert was
obtained in both orientations; in this study, all experi-
ments used the minus orientation in which the insert is
transcribed in the opposite direction of the GAL1 pro-
moter (see Additional file 3: Figure S4). Sequence was
verified by Sanger sequencing (Genscript).
Whole-genome sequencing (WGS) and analysis –
Fresh colonies from synthetic lethal mutants were cul-
tured overnight at 30 °C with shaking in 3 ml of YEPD+
Ade. Yeast were pelleted, washed with sterile water, and
shipped on ice to The Sequencing Center in Fort
Collins, Colorado. Whole-genome sequencing was
performed using the Illumina MiniSeq® platform with a
targeted mean coverage of ≈40–50×. Because the fully
annotated yeast genome is S288C, and our yeast were of
a W303 background, genome annotations were trans-
ferred from each S288C chromosome to the correspond-
ing W303 chromosomal sequences recently produced by
PacBio® sequencing (LYZE01000001–21; 47.0× coverage)
by Matheson et al. [57]. This annotation was done using
the BLAST-like “Annotate From …” alignment tool in
Geneious Prime 2019.2.3. Annotations were matched
using a generous similarity index of 80%. Paired reads
from WGS were mapped against this annotated W303
genome using the Geneious Prime “Map to Reference”
tool, and variants called. Automatically called variants
were manually analyzed to eliminate variants conserved
in our wild-type control, variants in non-coding se-
quences, and variants within regions of poor sequencing
coverage.
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